No Data
No Data
Maintain Market Perform: Balancing Potential and Uncertainty in AN2 Therapeutics' Drug Development
AN2 Therapeutics Is Maintained at In-Line by Evercore ISI Group
AN2 Therapeutics Is Maintained at In-Line by Evercore ISI Group
Express News | Evercore ISI Group Maintains In-Line on AN2 Therapeutics, Lowers Price Target to $2
Express News | AN2 Therapeutics Inc : Evercore ISI Cuts Target Price to $2 From $7
Analysts Are Bullish on These Healthcare Stocks: AN2 Therapeutics, Inc. (ANTX), Heron Therapeutics (HRTX)
TD Cowen Remains a Buy on AN2 Therapeutics, Inc. (ANTX)
No Data